Icecure Medical (ICCM) Income Statement (2019 - 2025)
Annual Income Statement report data from Dec 31, 2019 to Dec 31, 2025 for Icecure Medical (ICCM).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2021 | 2020 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||
Total Revenue | 3.38M (+2.74%) | 3.29M (+1.86%) | 3.23M (+4.53%) | 3.09M (-25.36%) | 4.14M (0.00%) | 4.14M (-72.40%) | 15M (+287.60%) | 3.87M (0.00%) | 3.87M (+137.42%) | 1.63M |
Cost Of Revenue | 2.15M (+16.85%) | 1.84M (-4.66%) | 1.93M (+17.68%) | 1.64M (-15.46%) | 1.94M (0.00%) | 1.94M | - | 1.42M (0.00%) | 1.42M (+29.09%) | 1.10M |
Costof Goods And Services Sold | 2.15M (+16.85%) | 1.84M (-4.66%) | 1.93M (+17.68%) | 1.64M (-15.46%) | 1.94M (0.00%) | 1.94M | - | 1.42M (0.00%) | 1.42M (+29.09%) | 1.10M |
Gross Profit | 1.23M (-15.17%) | 1.45M (+11.54%) | 1.30M (-10.34%) | 1.45M (-33.79%) | 2.19M (0.00%) | 2.19M | - | 2.44M (0.00%) | 2.44M (+369.23%) | 520K |
Operating Expenses | ||||||||||
Research And Development | 7.43M (+4.65%) | 7.10M (-14.15%) | 8.27M (-9.32%) | 9.12M (+55.10%) | 5.88M (0.00%) | 5.88M | - | 3.81M (0.00%) | 3.81M (+27.00%) | 3.00M |
Selling General And Administrative | 4.53M (+20.48%) | 3.76M (-9.83%) | 4.17M (+463.51%) | 740K (+311.11%) | 180K (-95.64%) | 4.13M | - | 120K (-92.98%) | 1.71M (+34.65%) | 1.27M |
Operating Expenses | 12M (+10.23%) | 11M (-12.78%) | 12M (+26.17%) | 9.86M (+62.98%) | 6.05M (-39.50%) | 10M | - | 3.93M (-28.80%) | 5.52M (+29.27%) | 4.27M |
Depreciation And Amortization | 300K (-9.09%) | 330K (+3.13%) | 320K (+28.00%) | 250K (+92.31%) | 130K (0.00%) | 130K | - | 60K (0.00%) | 60K (+100.00%) | 30K |
Operating Income | ||||||||||
Operating Income | -15.09M (-3.89%) | -15.70M (+0.77%) | -15.58M (-6.93%) | -16.74M (+72.22%) | -9.72M (0.00%) | -9.72M | - | -4.14M (0.00%) | -4.14M (-13.39%) | -4.78M |
Ebit | -15.09M (-3.89%) | -15.70M (+0.77%) | -15.58M (-6.93%) | -16.74M (+72.22%) | -9.72M (0.00%) | -9.72M | - | -4.14M (0.00%) | -4.14M (-13.39%) | -4.78M |
EBITDA | -14.80M (-3.65%) | -15.36M (+0.72%) | -15.25M (-7.52%) | -16.49M (+71.77%) | -9.60M (0.00%) | -9.60M | - | -4.08M (0.00%) | -4.08M (-14.11%) | -4.75M |
Other Income / Expenses | ||||||||||
Other Non Operating Income | 40K (-89.47%) | 380K (-58.70%) | 920K | -240.00K (+41.18%) | -170.00K (0.00%) | -170.00K | - | 410K (0.00%) | 410K (+78.26%) | 230K |
Net Income | ||||||||||
Net Income From Continuing Operations | -15.06M (-1.70%) | -15.32M (+4.57%) | -14.65M (-13.72%) | -16.98M (+71.69%) | -9.89M (0.00%) | -9.89M | - | -3.73M (0.00%) | -3.73M (-18.02%) | -4.55M |
Net Income | -15.06M (-1.70%) | -15.32M (+4.57%) | -14.65M (-13.72%) | -16.98M (+71.69%) | -9.89M (0.00%) | -9.89M | - | -3.73M (0.00%) | -3.73M (-18.02%) | -4.55M |
Comprehensive Income Net Of Tax | - | - | - | -16.98M (+71.69%) | -9.89M (0.00%) | -9.89M | - | -3.73M (0.00%) | -3.73M (-18.02%) | -4.55M |